Clinical Trial Update: NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung [NA]

View source ↗

Summary

Clinical trial of the NEUWAVE Flex Microwave Ablation System for primary soft tissue lung lesions was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• NEUWAVE Flex Microwave Ablation System

Snippet

Sponsor: Ethicon, Inc. | Conditions: Cancer of Lung, Cancer of the Lung | NA | Status: TERMINATED | Results posted: 2020-12-21